title: Allogeneic vs autologous BMT vs intensive chemotherapy in childhood AnLL during first complete remission: AIEOP experience. AIEOP Cooperative Group.
abstract: From 1982 to 1990, 340 children with newly diagnosed ANLL entered two consecutive AIEOP trials: LAM 8204 (1982-1987) and LAM 87 (1987-1990). Patients in both studies received identical remission induction with Daunorubicin and ARA-C. In the first study (LAM 8204) 167/171 patients were consolidated with four courses of DAT, followed by six additional courses of continuation therapy with three drug pairs given sequentially. Periodic intra-thecal ARA-C was used for CNS prophylaxis. For patients remaining on protocol, the OFS and EFS probability at 8 years was 35% and 30%, respectively. Induction response and EFS were adversely predicted by FAB MS subtype and hyperleukocytosis. In LAM 8204 trial there were 30 withdrawals represented by patients undergoing allogeneic (14) or autologous (16) BMT. For these patients the DFS probability at 5 years was 64% and 50%, respectively. On LAM-87 trial, 136/169 patients were evaluable and 98 (76%) attained CR. After consolidation with one course of DAT, patients with an HLA-identical donor underwent allogeneic BMT and those lacking a matched donor were randomized to receive either autologous BMT or the LAM 8204 postremission chemotherapy. The 2-year probability of DFS for allografted patients was 76% significantly higher (P = 0.0001) than that observed for patients on chemotherapy (12%) or autologous BMT (31%) arms.
authors.affiliation: Dpt. Human Biopathology, University La Sapienza, Roma, Italy.
authors.forename: W
authors.initials: W
authors.lastname: Arcese
authors.forename: S
authors.initials: S
authors.lastname: Amadori
authors.forename: A M
authors.initials: AM
authors.lastname: Testi
authors.forename: G
authors.initials: G
authors.lastname: Meloni
authors.forename: D
authors.initials: D
authors.lastname: Defazio
authors.forename: A
authors.initials: A
authors.lastname: Ceci
authors.forename: A
authors.initials: A
authors.lastname: Comelli
authors.forename: F
authors.initials: F
authors.lastname: Madon
authors.forename: G
authors.initials: G
authors.lastname: Masera
authors.forename: L
authors.initials: L
authors.lastname: Nespoli
mesh_terms: D000293:Adolescent; D016026:Bone Marrow Transplantation / Q000379:methods*; D002648:Child; D002675:Child, Preschool; D005602:France / Q000453:epidemiology; D006801:Humans; D007223:Infant; D007391:International Cooperation; D015470:Leukemia, Myeloid, Acute / Q000453:epidemiology / Q000601:surgery*; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous; D006113:United Kingdom / Q000453:epidemiology; D014481:United States / Q000453:epidemiology